CMSC Consensus Panel Guidance on the Use of Serum Neurofilament Light Chain in the Management of Multiple Sclerosis

home / peer-exchange / cmsc-consensus-panel-guidance-on-the-use-of-serum-neurofilament-light-chain-in-the-management-of

Expert thought leaders review the latest data and trends regarding the use of neurofilament light chain and other biomarkers in MS diagnosis and treatment.

This program is supported by Novartis Pharmaceuticals Corporation. Content is independently developed by CMSC.

© 2024 MJH Life Sciences

All rights reserved.